Navigation Links
Luxembourg joins EMBL
Date:11/12/2007

Today, the European Molecular Biology Laboratory [EMBL] announces Luxembourg as the new member of its international community. Accepted by EMBL's council and ratified by the parliament of Luxembourg, the Grand-Duchy has officially joined the institute as the 20th member state.

"EMBL is a key player in European molecular biology," says Franois Biltgen, Minister of Culture, Higher Education and Research, Luxembourg, "being part of its international network will provide a boost for Luxembourg's research in the growing field of molecular biology and will integrate its researchers even better into the European scientific community. In return Luxembourg will contribute to EMBL's various activities bringing in complementary strengths and technical expertise."

Through its membership Luxembourg will contribute to EMBL's pursuit of its five missions: to perform basic research in molecular biology; to train scientists, students and visitors at all levels; to offer vital services to scientists in the member states; to develop new instruments and methods in the life sciences and to actively engage in technology transfer activities. As a member state Luxembourg will benefit from the various services and training programmes that EMBL offers for its member states and it will have access to the research facilities at the five EMBL stations in Heidelberg and Hamburg, Germany, Grenoble, France, Hinxton, UK, and Monterotondo, Italy.

The delegate representing Luxembourg in EMBL's council will be Josiane Entringer of the Department for Research and Innovation of the Ministry for Culture, Higher Education and Research.

Luxembourg's activities in the molecular life sciences range from basic research in genetics, molecular biology and biomedicine to more applied areas such as cancer research and the development of health technologies. Since the foundation of its University in 2003, Luxembourg has actively contributed to education and training of Europe's scientific elite.

"We are very pleased to welcome Luxembourg as our new member state," says Iain Mattaj, Director General of EMBL, "Luxembourg has substantially contributed to the progress of research in the life sciences in the past years. Its overlapping research interests and its complementary expertise make it a very valuable addition to EMBL."


'/>"/>

Contact: Anna-Lynn Wegener
wegener@embl.de
49-622-138-7452
European Molecular Biology Laboratory
Source:Eurekalert

Related biology news :

1. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
2. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):
(Date:5/26/2016)... ... May 26, 2016 , ... FireflySci has been manufacturing quartz ... all over the globe. Their cute firefly logo has been spreading to more ... makes spectrophotometer calibration standards that never require recalibration. These revolutionary standards have ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Ankle ... plating options designed to address fractures of the distal tibia and fibula. This ... Acumed Ankle Plating System 3 is composed of seven plate families that span ...
(Date:5/25/2016)... ... ... Scientists at the University of Athens say they have evidence that the ... research that could lead to one good one. Surviving Mesothelioma has just posted an ... The team evaluated 98 mesothelioma patients who got a second kind of ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding ... has granted the company’s orphan drug designation request covering BHV-4157 for the treatment ... by the FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder ...
Breaking Biology Technology: